🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The focus of this study is to assess the safety of GSK's H1N1 vaccine in re...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-10-31
Trial ID
NCT00996853
Treatments Being Tested
The objective of this study is to evaluate the immunogenicity and safety of...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-10-14
Trial ID
NCT00992511
The purpose of the study is to evaluate the safety and immunogenicity of GS...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-08-11
Trial ID
NCT00951041
Treatments Being Tested
The purpose of the present study is to assess the immunogenicity, safety an...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-09-12
Trial ID
NCT00968890
Treatments Being Tested
This study is designed to characterize the safety and immunogenicity of pan...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-07-01
Trial ID
NCT01161160
Treatments Being Tested
The objective of this study is to evaluate the immunogenicity and safety of...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-10-07
Trial ID
NCT00989287
Treatments Being Tested
The objective of the study is to evaluate the immunogenicity and safety of ...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-09-08
Trial ID
NCT00971425
Treatments Being Tested
The purpose of this study is to assess the safety and immunogenicity of two...
Status
Terminated
Location
GSK Investigational Site
Start Date
2009-11-17
Trial ID
NCT01003418
The objective of this study is to evaluate the immunogenicity and safety of...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-09-29
Trial ID
NCT00972517
Treatments Being Tested
This trial is designed to assess the safety and immunogenicity of a prime-b...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-09-10
Trial ID
NCT00971321
Treatments Being Tested